(RTTNews) - Autonomix Medical, Inc. (AMIX), Wednesday announced that the European Patent Office has granted Patent No. 3,226,792 for the Company's catheter-based technology focused on ...

Continued progress with growing global patent portfolio to over 80 issued patents and 40 pending patent applications THE WOODLANDS, TX, April 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc ...

THE WOODLANDS, TX, April 16, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ ... today announced that European Patent Office (EPO) has granted Patent No. 3,226,792 (the ‘792) titled ...

(“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today ...

Image credit: superbeststock via Shutterstock. Nexalin has received patent approval from the United States Patent and Trademark Office (USPTO) for its deep intracranial frequency stimulation (DIFS) ...

We also do a deep dive on drug patents — how they’re obtained, how they’re used, and how they can mean the difference between a drug costing hundreds of dollars or the equivalent of a cup of ...

BEDMINSTER, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI), today announced the issuance of a second U.S. patent in its growing patent family titled ...

BEDMINSTER, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI), today announced the issuance of a second U.S. patent in its growing patent family titled ...

BEDMINSTER, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI), today announced the issuance of a second U.S. patent in its growing patent family titled ...

Veracode, a global leader in application risk management, announced today it has been granted a United States patent for its generative artificial intelligence security tool, Veracode Fix.

Mumbai: Lyka Labs Limited has announced that it has been granted an Indian Patent for its proprietary product, Pregabalin Gel 8 percent, with patent protection valid through 2043. Pregabalin Gel 8%, a ...